SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 336 filers reported holding SHOCKWAVE MED INC in Q2 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,892 | +493.1% | 9,505 | +751.7% | 0.02% | +1000.0% |
Q2 2023 | $319 | -49.3% | 1,116 | -61.5% | 0.00% | -71.4% |
Q1 2023 | $629 | +144.7% | 2,899 | +131.5% | 0.01% | +133.3% |
Q4 2022 | $257 | -100.0% | 1,252 | -89.0% | 0.00% | -92.3% |
Q3 2022 | $3,154,000 | +134.5% | 11,341 | +61.2% | 0.04% | +178.6% |
Q2 2022 | $1,345,000 | -14.3% | 7,034 | -7.1% | 0.01% | +16.7% |
Q1 2022 | $1,570,000 | +88.9% | 7,570 | +62.4% | 0.01% | +140.0% |
Q4 2021 | $831,000 | -75.9% | 4,662 | -72.2% | 0.01% | -68.8% |
Q3 2021 | $3,453,000 | +11.4% | 16,771 | +2.7% | 0.02% | +14.3% |
Q2 2021 | $3,099,000 | +3.9% | 16,336 | -28.6% | 0.01% | -12.5% |
Q1 2021 | $2,982,000 | +22.6% | 22,889 | -2.4% | 0.02% | +23.1% |
Q4 2020 | $2,433,000 | +135.1% | 23,454 | +71.7% | 0.01% | +85.7% |
Q3 2020 | $1,035,000 | +25.3% | 13,656 | -21.7% | 0.01% | 0.0% |
Q2 2020 | $826,000 | +145.1% | 17,440 | +71.7% | 0.01% | +133.3% |
Q1 2020 | $337,000 | -18.2% | 10,156 | -26.2% | 0.00% | 0.0% |
Q3 2019 | $412,000 | – | 13,767 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
Matisse Capital | 22,175 | $4,415,043 | 3.12% |
Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
AtonRa Partners | 4,374 | $870,863 | 1.83% |
Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |